|
|
|
Last Modified 1 Dec 2008 |
Announce
Docking Study with HyperChem, Revision E1 - Carrying The Next-generation Drug Discovery Technology, The PIEFII Technology -
Powered by Docking Study with HyperChem THE IMPOSSIBLE BECOMES POSSIBLE. Advanced Technology & The High-Performance, Biomacromolecule- & Ligand-Flexible Docking & Screening Program Package Docking Study with HyperChem supports the comprehensive and automatic biomacromolecule (protein and nucleic acid molecule systems)- and ligand (small molecule and peptide)-flexible docking simulations, and thus supports the drug design and the in silico screening of a drug candidate. Homology Modeling Professional for HyperChem, Revision E1 with Gaussian Interface for HyperChem & ONIOM Interface for Receptor
Powered by Homology Modeling for HyperChem THE IMPOSSIBLE BECOMES POSSIBLE. New, High-Performance Software for Protein Modeling, Functional Analysis, and Simulation. Homology Modeling for HyperChem is the latest molecular modeling package which can carry out the molecular modeling, functional analysis, and simulations of a big molecular system using comprehensively the ab-initio quantum chemistry calculations and the molecular dynamics simulations as well as the molecular mechanics calculations. The program can control seamlessly both HyperChem and Gaussian03 packages and can be simultaneously fed back their calculation results to the big molecular system in the HyperChem graphical user interface. The whole molecular system can be operated in a quantum chemistry via the full-automatic ONIOM interface to Gaussian. All operations are fully automated in the GUI-based manner, and thus the program supports the logical molecular modeling, functional analysis, and simulations in the life science research such as the structure-based drug design, as well as an unexplored research.
The Next-generation Drug Discovery Technology Ab-Initio Protein-Ligand Interaction Site & Potential Ligand Prediction Technology
Topics 2008/02 Docking Study with HyperChem and Homology Modeling Professional for HyperChem were introduced in an article. Science. 2008 Feb 1; 319 (5863): 624-7. 2007/06/16 We really appreciate great cooperation of Neil S. Ostlund, President and Chief Executive Officer of Hypercube, Inc.
Latest News Archives 2008/12/01 Altered the licensing system of Docking Study with HyperChem to the perpetual license from the annual license. Simultaneously, changed the restricted number of atoms to 1,000 from 500 in the PIEFII program. Modified some contents of the upgrade, revision update, maintenance, and support.
* HyperChem is a registered trademark of Hypercube, Inc. *" Gaussian is a registered trademark of Gaussian, Inc.
|
|
Site Map |
